Crosstalk between gut–brain axis: unveiling the mysteries of gut ROS in progression of Parkinson’s disease
Authors:
- 11 July 2024
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 32 (5) , 2921-2941
Abstract
“Path to a good mood lies through the gut.” This statement seems to imply that it has long been believed that the gut is connected with the brain. Research has shown that eating food activates the reward system and releases dopamine (DA), establishing a link between the peripheral and central nervous system. At the same time, researchers also trust that the gut is involved in the onset of many diseases, including Parkinson’s disease (PD), in which gastrointestinal dysfunction is considered a prevalent symptom. Reports suggest that PD starts from the gut and reaches the brain via the vagus nerve. Recent studies have revealed an intriguing interaction between the gut and brain, which links gut dysbiosis to the etiology of PD. This review aims to explore the mechanistic pathway how reactive oxygen species (ROS) generation in the gut affects the makeup and operation of the dopamine circuitry in the brain. Our primary concern is ROS generation in the gut, which disrupts the gut microbiome (GM), causing α-synuclein accumulation and inflammation. This trio contributes to the loss of DA neurons in the brain, resulting in PD development. This review also compiles pre-clinical and clinical studies on antioxidants, demonstrating that antioxidants reduce ROS and increase DA levels. Collectively, the study highlights the necessity of comprehending the gut–brain axis for unraveling the riddles of PD pathogenesis and considering new therapeutic approaches. Graphical abstractKeywords
This publication has 131 references indexed in Scilit:
- Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson’s Disease Mice via Inhibiting TLR4/NF-κB SignalingNeurochemical Research, 2023
- Neuroprotective Effects of Lycium Barbarum Fruit Extract on Pink1B9Drosophila Melanogaster Genetic Model of Parkinson’s DiseasePlant Foods for Human Nutrition, 2022
- An Alternative Explanation for Alzheimer’s Disease and Parkinson’s Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and NeurotoxinsNeurochemical Research, 2021
- Protective mechanism of Syringic acid in an experimental model of Parkinson’s diseaseMetabolic Brain Disease, 2021
- Do your gut microbes affect your brain dopamine?Psychopharmacology, 2019
- Neurotherapeutic Effects of Bee Venom in a Rotenone-Induced Mouse Model of Parkinson’s DiseaseNeurophysiology, 2018
- Colonic bacterial composition in Parkinson's diseaseMovement Disorders, 2015
- Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in ratsActa Neuropathologica, 2014
- Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α‐synucleinJournal of Neuroscience Research, 2011
- Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systemsJournal of Cellular Physiology, 2005